Eichelbaum M, Bertilsson L, Küpfer A, Steiner E, Meese C O
Dr Margarete Fischer-Bosch-Institut für Klinische Pharmakologie, Stuttgart, FRG.
Br J Clin Pharmacol. 1988 Apr;25(4):505-8. doi: 10.1111/j.1365-2125.1988.tb03335.x.
Debrisoquine (DQ) has no chiral centre, but hydroxylation in position 4 leads to formation of an asymmetric carbon centre with two possible enantiomers, their absolute configuration being R(-) and S(+)-4-hydroxydebrisoquine (4-OHDQ). Since the absolute stereochemistry of the 4-hydroxylation of DQ in man is unknown, the enantioselectivity of this process was studied in panels of extensive (EM) and poor metabolizers (PM) of DQ. In EM subjects 4-hydroxylation of DQ leads almost exclusively to the formation of S(+)-4-OHDQ. In contrast, PM subjects were not only characterized by a decreased total 4-OHDQ formation but also a marked loss of enantioselectivity in product formation. Between 5 to 36% of total 4-OHDQ was excreted as R(-)-4-OHDQ.
异喹胍(DQ)没有手性中心,但4位的羟基化会导致形成一个具有两种可能对映体的不对称碳中心,它们的绝对构型分别为R(-)-和S(+)-4-羟基异喹胍(4-OHDQ)。由于人体中DQ 4-羟基化的绝对立体化学尚不清楚,因此在异喹胍广泛代谢者(EM)和代谢不良者(PM)群体中研究了该过程的对映选择性。在EM受试者中,DQ的4-羟基化几乎只导致S(+)-4-OHDQ的形成。相比之下,PM受试者不仅表现为4-OHDQ总生成量减少,而且产物形成中的对映选择性也明显丧失。总4-OHDQ中有5%至36%以R(-)-4-OHDQ的形式排泄。